Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener klinische Wochenschrift
Erschienen in:

29.06.2018 | review article

Diagnosis of Helicobacter pylori infection

A short review

verfasst von: Ante Tonkic, Jonatan Vukovic, Pavle Vrebalov Cindro, Valdi Pesutic Pisac, Marija Tonkic

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 17-18/2018

Einloggen, um Zugang zu erhalten

Summary

Helicobacter pylori infections represent an important factor in the pathogenesis of chronic gastritis, peptic ulcer, MALT lymphoma and gastric adenocarcinoma. The recently published Maastricht V/Florence consensus report indicated that the urea breath test using 13 C urea still remains the best non-invasive test to diagnose H. pylori infections with high sensitivity and specificity. Among the stool antigen tests, the ELISA monoclonal antibody test is a rational option. Effective therapy should be based only on susceptibility testing in regions with documented high clarithromycin resistance (>15%). Advanced high-resolution endoscopic technologies enable increased diagnostic accuracy for detection of H. pylori infections.
Vorheriger Artikel Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives
Nächster Artikel Austrian recommendations for the management of polycythemia vera
Literatur
1.
European Helicobacter and Microbiota Study Group, Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection- the Maastricht V/Florence consenus report. Gut. 2017;66:6–30.CrossRef
2.
3.
Tonkic A, Tonkic M, Lehours P, et al. Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter. 2012;17(Suppl 1):1–8.CrossRefPubMed
4.
Gisbert JP, Pajares JM. Review article: 13 C-urea breath test in the diagnosis of Helicobacter pylori infection—a critical review. Aliment Pharmacol Ther. 2004;20:1001–17.CrossRefPubMed
5.
Epple HJ, Kirstein FW, Bojarski C, et al. 13 C-urea breath test in Helicobacter pylori diagnosis and eradication. Correlation to histology, origin of ‘false’ results, and influence of food intake. Scand J Gastroenterol. 1997;32:308–14.CrossRefPubMed
6.
Ferwana M, Abdulmajeed I, Alhajiahmed A, et al. Accuracy of urea breath test in Helicobacter pylori infection: meta-analysis. World J Gastroenterol. 2015;21:1305–14.CrossRefPubMedPubMedCentral
7.
Pathak CM, Kaur B, Bhasin DK, et al. Comparison of encapsulated versus nonencapsulated (14) C‑urea breath test for the detection of Helicobacter pylori infection: a scintigraphy study. Helicobacter. 2014;19:116–23.CrossRefPubMed
8.
Graham DY, Opekun AR, Hammoud F, et al. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol. 2003;98:1005–9.CrossRefPubMed
9.
McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med. 2010;362:1597–604.CrossRefPubMed
10.
Gisbert JP, de la Morena F, Abraira V. Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. Am J Gastroenterol. 2006;101:1921–30.CrossRefPubMed
11.
Leodolter A, Domínguez-Muñoz JE, von Arnim U, et al. Validity of a modified13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting. Am J Gastroenterol. 1999;94:2100–4.CrossRefPubMed
12.
Calvet X, Lario S, Ramírez-Lázaro MJ, et al. Comparative accuracy of 3 monoclonal stool tests for diagnosis of Helicobacter pylori infection among patients with dyspepsia. Clin Infect Dis. 2010;50(3):323–8.CrossRefPubMed
13.
Vaira D, Vakil N, Menegatti M, et al. The stool antigen test for detection of Helicobacter pylori after eradication therapy. Ann Intern Med. 2002;136:280–7.CrossRefPubMed
14.
Zhou X, Su J, Xu G, et al. Accuracy of stool antigen test for the diagnosis of Helicobacter pylori infection in children: a meta-analysis. Clin Res Hepatol Gastroenterol. 2014;38:629–38.CrossRefPubMed
15.
16.
Manes G, Balzano A, Iaquinto G, et al. Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy. Aliment Pharmacol Ther. 2001;15:73–9.CrossRefPubMed
17.
Burucoa C, Delchier JC, Courillon-Mallet A, et al. Comparative evaluation of 29 commercial Helicobacter pylori serological kits. Helicobacter. 2013;18:169–79.CrossRefPubMed
18.
Ho B, Marshall BJ. Accurate diagnosis of Helicobacter pylori. Serologic testing. Gastroenterol Clin North Am. 2000;29:853–62.CrossRefPubMed
19.
Michel A, Pawlita M, Boeing H, et al. Helicobacter pylori antibody patterns in Germany: a cross-sectional population study. Gut Pathog. 2014;6:10.CrossRefPubMedPubMedCentral
20.
Camargo MC, Beltran M, Conde-Glez CJ, et al. Serological response to Helicobacter pylori infection among Latin American populations with contrasting risks of gastric cancer. Int J Cancer. 2015;137:3000–5.CrossRefPubMedPubMedCentral
21.
McNulty CA, Lehours P, Mégraud F. Diagnosis of Helicobacter pylori Infection. Helicobacter. 2011;16(Suppl 1):10–8.CrossRefPubMed
22.
Feldman RA, Deeks JJ, Evans SJ. Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Helicobacter pylori Serology Study Group. Eur J Clin Microbiol Infect Dis. 1995;14:428–33.CrossRefPubMed
23.
Qi Q, Guo C, Ji R, et al. Diagnostic performance of magnifying endoscopy for Helicobacter pylori infection: a meta-analysis. PLoS ONE. 2016;11(12):e168201.CrossRefPubMedPubMedCentral
24.
Yagi K, Honda H, Yang JM, et al. Magnifying endoscopy in gastritis of the corpus. Endoscopy. 2005;37:660–6.CrossRefPubMed
25.
East JE, Vleugels JL, Roelandt P, et al. Advanced endoscopic imaging: European Society of Gastrointestinal Endoscopy (ESGE). Technol Rev. 2016;48:1029–45.
26.
Tseng CA, Wang WM, Wu DC. Comparison of the clinical feasibility of three rapid urease tests in the diagnosis of Helicobacter pylori infection. Dig Dis Sci. 2005;50:449–52.CrossRefPubMed
27.
Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808–25.CrossRefPubMed
28.
Vaira D, Vakil N, Gatta L, et al. Accuracy of a new ultrafast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive dyspeptic patients. Aliment Pharmacol Ther. 2010;31:331–8.PubMed
29.
Attumi TA, Graham DY. Follow-up testing after treatment of Helicobacter pylori infections: cautions, caveats, and recommendations. Clin Gastroenterol Hepatol. 2011;9:373–5.CrossRefPubMed
30.
Gisbert JP, Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol. 2006;101:848–63.CrossRefPubMed
31.
Laine L, Estrada R, Trujillo M, et al. Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med. 1998;129:547–50.CrossRefPubMed
32.
Lan HC, Chen TS, Li AF, et al. Additional corpus biopsy enhances the detection of Helicobacter pylori infection in a background of gastritis with atrophy. BMC Gastroenterol. 2012;12:182.CrossRefPubMedPubMedCentral
33.
Moon SW, Moon SW, Kim TH, et al. United rapid urease test is superior than separate test in detecting Helicobacter pylori at the gastric antrum and body specimens. Clin Endosc. 2012;45:392–6.CrossRefPubMedPubMedCentral
34.
35.
Hartman DJ, Owens SR. Are routine ancillary stains required to diagnose Helicobacter infection in gastric biopsy specimens? An institutional quality assurance review. Am J Clin Pathol. 2012;137:255–60.CrossRefPubMed
36.
El-Zimaity HM, Segura AM, Genta RM, et al. Histologic assessment of Helicobacter pylori status after therapy: comparison of Giemsa, Diff-Quik, and Genta stains. Mod Pathol. 1998;11:288–91.PubMed
37.
Smith SB, Snow AN, Perry RL, et al. Helicobacter pylori: to stain or not to stain? Am J Clin Pathol. 2012;137:733–8.CrossRefPubMed
38.
Wang XI, Zhang S, Abreo F, et al. The role of routine immunohistochemistry for Helicobacter pylori in gastric biopsy. Ann Diagn Pathol. 2010;14:256–9.CrossRefPubMed
39.
Genta RM, Graham DY. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc. 1994;40:342–5.CrossRefPubMed
40.
Satoh K, Kimura K, Taniguchi Y, et al. Biopsy sites suitable for the disgnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis. Am J Gastroenterol. 1998;93:569–73.CrossRefPubMed
41.
Dixon MF, Genta Yardley JHP, et al. Classification and grading of gastritis. The updated Sidney System. Am J Surg Pathol. 1996;20:1161–81.CrossRefPubMed
42.
Rugge M, Pennelli G, Pilozzi E, et al. Gastritis: the histology report. Dig Liver Dis. 2011;43:S373–S84.CrossRefPubMed
43.
Walsh J, Moran AP. Influence of medium composition on the growth and antigen expression of Helicobacter pylori. J Appl Microbiol. 1997;83:67–75.CrossRefPubMed
44.
45.
Yuen B, Zbinden R, Fried M, et al. Cultural recovery and determination of antimicrobial susceptibility in Helicobacter pylori by using commercial transport and isolation media. Infection. 2005;33:77–81.CrossRefPubMed
46.
Gong YN, Li YM, Yang NM, et al. Centralized isolation of Helicobacter pylori from multiple centers and transport condition influences. World J Gastroenterol. 2015;21:944–52.CrossRefPubMedPubMedCentral
47.
Leszczyńska K, Namiot A, Namiot Z, et al. Patient factors affecting culture of Helicobacter pylori isolated from gastric mucosal specimens. Adv Med Sci. 2010;55:161–6.CrossRefPubMed
48.
Wang YK, Kuo FC, Liu CJ, et al. Diagnosis of Helicobacter pylori infection: current options and developments. World J Gastroenterol. 2015;21:11221–35.CrossRefPubMedPubMedCentral
49.
Lopes AI, Vale FF, Oleastro M. Helicobacter pylori infection—recent developments in diagnosis. World J Gastroenterol. 2014;20:9299–313.PubMedPubMedCentral
50.
Giorgio F, Ierardi E, Sorrentino C. Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis. Scand J Gastroenterol. 2016;51(12):1429–32.CrossRefPubMed
51.
Miendje Deyi VY, Burette A, Bentatou Z, et al. Practical use of GenoType® HelicoDR, a molecular test for Helicobacter pylori detection and susceptibility testing. Diagn Microbiol Infect Dis. 2011;70:557–60.CrossRefPubMed
52.
Lee JW, Kim N, Nam RH, et al. GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea. Scand J Gastroenterol. 2014;49:1058–67.CrossRefPubMed
53.
Cerqueira L, Fernandes RM, Ferreira RM, et al. Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens. J Clin Microbiol. 2013;51:1887–93.CrossRefPubMedPubMedCentral
Metadaten
Titel
Diagnosis of Helicobacter pylori infection
A short review
verfasst von
Ante Tonkic
Jonatan Vukovic
Pavle Vrebalov Cindro
Valdi Pesutic Pisac
Marija Tonkic
Publikationsdatum
29.06.2018
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 17-18/2018
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-018-1356-6

Weitere Artikel der Ausgabe 17-18/2018

Predictors of colonic pathologies in active acromegaly: single tertiary center experience

  • original article

Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives

  • Open Access
  • review article

Schatzki ring

  • images in clinical medicine

Ruxolitinib therapy for myelofibrosis in Austria

  • Open Access
  • original article

Clinical-Pathological Conference Series from the Medical University of Graz

  • Open Access
  • clinical-pathological conference

Correction to: S(+)-ketamine

  • Correction